Veterinary Researchers: Let More Money Go To The Dogs

Although $12 billion a year is spent in the U.S. for pet food and care, research funding for companion animal health falls short Three-year-old Jessie, her gums white from blood loss, was rushed, hemorrhaging and near death, to the emergency room of a Canadian hospital. Test results showed that she was suffering from massive ulcers brought on by an over-the-counter anti-inflammatory medication she had been given to treat a hip condition. After a surgeon at the hospital removed the largest ulce

Written byRobin Eisner
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

After two weeks, Jessie was up on all fours again, barking at the mailman. And now, a year later, she's "her beautiful, bouncy, Great Dane self again," says Papich.

"Her owners had given Jessie the [anti-inflammatory] drug thinking it could help her, but they didn't know it would hurt her," adds Papich, an associate professor of clinical pharmacology at the Western College of Veterinary Medicine in Saskatoon, Saskatchewan.

The development of the drug Tagamet and its successful application in Jessie's case is a prime example of a not-infrequent occurrence of research originally performed on lab animals for the sake of humans that is eventually found to benefit animals as well. Today, for instance, veterinarians routinely perform prosthetic hip replacements and pacemaker implants on dogs--two procedures initially tried on dogs before they were done on humans.

The sorry side of this, in the view of many scientists, is that, with rare ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies